Position in GILD
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$24,765,166
+$13,782,810 QoQ
Shares Held
196,020
+148.8% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#299
of 2,266 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Covea Finance holds $67,956,643 across 2 Drug Manufacturers - General names. GILD ranks #2 (36.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
36,010 | $43,191,477 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
196,020 | $24,765,166 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,765,166 | 196,020 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $10,982,356 | 78,800 | Shares | Sole | 2026-04-15 | |
| 2025-09-30 | $5,738,700 | 51,700 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,731,979 | 51,700 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $3,417,525 | 30,500 | Shares | Sole | 2025-04-22 | |
| No filing history on record for this holder in this stock. | ||||||